MARTINGALE ASSET MANAGEMENT L P

Position in TRDA — Entrada Therapeutics, Inc.

CIK 936944 BOSTON, MA

Position in TRDA

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$281,615

-$245,434 QoQ

Shares Held

38,263

-8.4% QoQ

Ownership

0.098%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#55

of 128 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 48% Shared 0% None 52%

Healthcare · as of Jun 30, 2026

MARTINGALE ASSET MANAGEMENT L P holds $144,833,314 across 62 Biotechnology names. TRDA ranks #54 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	42,729	$21,224,776
2	INCY	Incyte Corp	168,818	$19,137,208
3	JAZZ	Jazz Pharmaceuticals plc	59,492	$14,335,787
4	REGN	Regeneron Pharmaceuticals, Inc.	18,953	$11,817,953
5	LGND	Ligand Pharmaceuticals Inc	17,562	$5,551,172
6	ACAD	Acadia Pharmaceuticals Inc	167,893	$4,247,692
7	ALNY	Alnylam Pharmaceuticals, Inc.	13,634	$4,104,243
8	INVA	Innoviva, Inc.	165,115	$3,749,761

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$281,615	38,263	-8.4%	Shares	Sole	2026-08-13
2026-03-31	$527,049	41,763	+12.7%	Shares	Sole	2026-05-13
2025-12-31	$380,904	37,053	0.0%	Shares	Sole	2026-02-13
2025-09-30	$214,907	37,053	-6.1%	Shares	Sole	2025-11-13
2025-06-30	$265,191	39,463	-1.7%	Shares	Sole	2025-08-11
2025-03-31	$363,073	40,163	+4.0%	Shares	Sole	2025-05-14
2024-12-31	$667,791	38,623	+1.8%	Shares	Sole	2025-02-13
2024-09-30	$606,008	37,923	+36.9%	Shares	Sole	2024-11-14
2024-06-30	$394,681	27,697	+50.1%	Shares	Sole	2024-08-12
2024-03-31	$261,464	18,452	—	Shares	Sole	2024-05-14
No filing history on record for this holder in this stock.